Viewing Study NCT02504892


Ignite Creation Date: 2025-12-24 @ 3:33 PM
Ignite Modification Date: 2026-03-02 @ 4:37 PM
Study NCT ID: NCT02504892
Status: TERMINATED
Last Update Posted: 2019-03-22
First Post: 2015-07-21
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Everolimus Therapy in People With Birt-Hogg-Dube Syndrome (BHD)-Associated Kidney Cancer or Sporadic Chromophobe Renal Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Renal Cancer View
None Birt-Hogg-Dube Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Overall Response Rate View
None Hereditary Cancer Syndrome View
None mTOR Therapy Naive View